MYRIAD ASSET MANAGEMENT US LP – CymaBay Therapeutics, Inc. Transaction History
MYRIAD ASSET MANAGEMENT US LP portfolio value:
$0
portfolio value
MYRIAD ASSET MANAGEMENT US LP quarter portfolio value change:
+18.64%
quarter
CymaBay Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -30K shares | -89K | $3.5 | 0 |
| Q2 2022 | share | Increase | 0.00% | 30K shares | 89K | $2.95 | 30K |